E. Saesen, Bases structurales de la régulation des cytokines par les héparanes sulfates: régulation génique et optimisation d'un inhibiteur de l'interféron-gamma, p.296

, Les bases de l'immunologie fondamentale et clinique -9782294752421 |

, ebooks, revues et traités EMC pour toutes spécialités médicales et paramédicales

D. Sur,

F. Altare and J. Casanova, IL-12 et IFN-? : un axe clé de l'immunité antimycobactérienne chez l'homme. médecine/sciences, vol.17, pp.1112-1121, 2001.

F. Lefèvre, Le système interféron : structure, biologie, applications. Ann Rech Vét, vol.20, p.38, 1989.

D. Sur,

, /S0969212601005676?token=26D837A768CE277BAF61E8A2E48E 916E3F4D94475F6D0F1134B463E7A2B3A4F46373637E051D107D2717

Y. Hamon, C. M. Blouin, C. Lamaze, and H. He, Dynamiques moléculaire et membranaire du récepteur de l'interféron gamma : pour un sucre de trop ! médecine/sciences, vol.33, pp.707-717, 2017.

A. Esteve-solé, I. Sologuren, M. T. Martínez-saavedra, À. Deyà-martínez, C. Oleaga-quintas et al., Laboratory evaluation of the IFN-? circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease, Crit Rev Clin Lab Sci. mai, vol.55, issue.3, pp.184-204, 2018.

X. Hu and L. B. Ivashkiv, Cross-regulation of Signaling and Immune Responses by IFN-? and STAT1. Immunity, vol.31, p.50, 2009.

T. Decker, D. J. Lew, J. Mirkovitch, and J. E. Darnell, Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor, EMBO J. avr, vol.10, issue.4, pp.927-959, 1991.

J. Casanova, S. M. Holland, and L. D. Notarangelo, Inborn Errors of Human JAKs and STATs, Immunity. 20 avr, vol.36, issue.4, p.28, 2012.

G. M. Boxx and G. Cheng, The Roles of Type I Interferon in Bacterial Infection, Cell Host Microbe. juin, vol.19, issue.6, pp.760-769, 2016.

J. Purkerson and P. Isakson, A two-signal model for regulation of immunoglobulin isotype switching, FASEB J. nov, vol.6, issue.14, p.52, 1992.

J. R. Schoenborn and C. B. Wilson, Regulation of Interferon-? During Innate and Adaptive Immune Responses, Advances in Immunology

E. Torrado and A. M. Cooper, CYTOKINES IN THE BALANCE OF PROTECTION AND PATHOLOGY DURING MYCOBACTERIAL INFECTIONS, Adv Exp Med Biol, vol.783, pp.121-161, 2013.

K. Früh and Y. Yang, Antigen presentation by MHC class I and its regulation by interferon ?, Curr Opin Immunol. févr, vol.11, issue.1, p.81, 1999.

, Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity, J Exp Med. 1 sept, vol.158, issue.3, p.89, 1983.

P. S. Subramaniam, J. L. Iii, M. G. Mujtaba, M. R. Walter, and H. M. Johnson, The COOHterminal nuclear localization sequence of interferon ? regulates STAT1? nuclear translocation at an intracellular site, p.11

K. Schroder, P. J. Hertzog, T. Ravasi, and D. A. Hume, Interferon-?: an overview of signals, mechanisms and functions, J Leukoc Biol, vol.75, issue.2, p.89, 2004.

T. Mémoire and . Farez, Maîtrise en médecine expérimentale de l

D. Sur,

A. Mishra, S. Akhtar, C. Jagannath, and A. Khan, Pattern recognition receptors and coordinated cellular pathways involved in tuberculosis immunopathogenesis: Emerging concepts and perspectives, Mol Immunol. juill, vol.87, pp.240-248, 2017.

F. Valour, T. Perpoint, A. Sénéchal, X. Kong, J. Bustamante et al., Interferon-? Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection, Emerg Infect Dis. juin, vol.22, issue.6, pp.1124-1130, 2016.

. Netgen, Mycobactéries non tuberculeuses : quoi de neuf ?

. Revue-médicale-suisse, Infections mycobactériennes non tuberculeuses -Maladies infectieuses, Édition professionnelle du Manuel MSD

D. Sur,

P. Haslett, J. D. Klausner, S. Makonkawkeyoon, A. Moreira, and P. Metatratip,

B. Boyle, Thalidomide Stimulates T Cell Responses and Interleukin, vol.12

, Production in HIV-Infected Patients

D. Sur,

Y. Koizumi, T. Sakagami, N. Nishiyama, J. Hirai, Y. Hayashi et al., Rituximab Restores IFN-?-STAT1 Function and Ameliorates Disseminated Mycobacterium avium Infection in a Patient with Anti-Interferon-?

. Autoantibody, J Clin Immunol, vol.37, issue.7, p.9, 2017.

P. Chetchotisakd, S. Anunnatsiri, R. Nanagara, A. Nithichanon, and G. Lertmemongkolchai, Intravenous Cyclophosphamide Therapy for Anti-IFN-Gamma Autoantibody-Associated Mycobacterium abscessus Infection

, J Immunol Res, vol.30, 2018.

S. Boisson-dupuis, J. Bustamante, J. El-baghdadi, Y. Camcioglu, N. Parvaneh et al., Inherited and acquired immunodeficiencies underlying tuberculosis in childhood, Immunol Rev. mars, vol.264, issue.1, p.20, 2015.

J. Casanova, M. E. Conley, S. J. Seligman, L. Abel, and L. D. Notarangelo, Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies, J Exp Med, vol.211, issue.11, pp.2137-2186, 2014.

H. Qu, S. P. Fisher-hoch, and J. B. Mccormick, Molecular immunity to mycobacteria: knowledge from the mutation and phenotype spectrum analysis of Mendelian susceptibility to mycobacterial diseases, Int J Infect Dis IJID Off Publ Int Soc Infect Dis. mai, vol.15, issue.5, pp.305-318, 2011.

J. Bustamante, S. Boisson-dupuis, A. L. Casanova, and J. , Mendelian susceptibility to mycobacterial disease: Genetic, immunological, and clinical features of inborn errors of IFN-? immunity, Semin Immunol. déc, vol.26, issue.6, pp.454-70, 2014.

D. Mansouri, P. Adimi, M. Mirsaeidi, N. Mansouri, S. Khalilzadeh et al., Inherited disorders of the IL-12-IFN-? axis in patients with disseminated BCG infection, Eur J Pediatr. déc, vol.164, issue.12, pp.753-760, 2005.

I. Sologuren, S. Boisson-dupuis, J. Pestano, Q. B. Vincent, L. Fernández-pérez et al., Partial recessive IFN-?R1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds, Hum Mol Genet. 15 avr, vol.20, issue.8, pp.1509-1532, 2011.

, Inherited disorders of cytokines | Ovid

D. Sur,

S. E. Dorman and S. M. Holland, Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection, J Clin Invest. 1 juin, vol.101, issue.11, pp.2364-2373, 1998.

, Syndrome de susceptibilite mendélienne aux infections mycobacteriennes : défauts de l'axe Interleukine-12 -Interféron-? -EM|consulte

F. Bustamante, J. Chapgier, A. Vogt, G. De-beaucoudrey, L. Feinberg et al., Inborn errors of IL-12/23-and IFN-?-mediated immunity: molecular, cellular, and clinical features, Semin Immunol. déc, vol.18, issue.6, p.61, 2006.

F. Jabot-hanin, Recherche des facteurs génétiques contrôlant la réponse à l'infection par Mycobacterium tuberculosis et le développement d'une tuberculose maladie, p.213, 2017.

C. Fieschi and H. Saint-louis, Déficits immunitaires de l'adulte, p.70

S. K. Browne, P. D. Burbelo, P. Chetchotisakd, Y. Suputtamongkol, S. Kiertiburanakul et al., Adult-onset immunodeficiency in Thailand and Taiwan, N Engl J Med. 23 août, vol.367, issue.8, p.725, 2012.

C. Höflich, R. Sabat, S. Rosseau, B. Temmesfeld, H. Slevogt et al., Naturally occurring anti-IFN-? autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans, Blood. 15 janv, vol.103, issue.2, p.5, 2004.

J. Picque, M. Blot, R. Binois, G. Jeudy, A. Simonet et al., Infections récurrentes à mycobactéries atypiques chez l'adulte : attention aux autoanticorps anti-interféron-gamma ! Rev Médecine Interne, vol.33, pp.103-109, 2012.

L. G. Hanitsch, M. Löbel, H. Müller-redetzky, M. Schürmann, N. Suttorp et al., Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies, J Clin Immunol. mai, vol.35, issue.4, pp.361-366, 2015.

J. Chan, N. J. Trendell-smith, J. Chan, I. Hung, B. Tang et al., Reactive and Infective Dermatoses Associated with Adult-Onset Immunodeficiency due to Anti-Interferon-Gamma Autoantibody: Sweet's Syndrome and Beyond, Dermatology, vol.226, issue.2, pp.157-66, 2013.

K. Shima, T. Sakagami, Y. Tanabe, N. Aoki, H. Moro et al., Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients, J Infect Chemother. janv, vol.20, issue.1, pp.52-58, 2014.

E. O'connell, L. B. Rosen, R. W. Larue, V. Fabre, M. T. Melia et al., The First US Domestic Report of Disseminated Mycobacterium avium Complex and Anti-Interferon-? Autoantibodies, J Clin Immunol, vol.34, issue.8, pp.928-960, 2014.

T. Yamada, S. Iwakami, S. Hara, N. Iwakami, A. Nakamura et al., Disseminated non-tuberculous mycobacterial infection caused by antiinterferon-? autoantibodies in a patient of very advanced age, Geriatr Gerontol Int, vol.18, issue.7, pp.1132-1135, 2018.

A. Yerramilli, G. Huang, D. Griffin, K. L. Kong, S. Muhi et al., Disseminated Nontuberculous Mycobacterial Infection Associated With Acquired Immunodeficiency Due to Anti-Interferon ? Autoantibodies

, Open Forum Infect Dis, vol.16

D. Sur,

H. Namkoong, T. Asakura, M. Ishii, S. Yoda, K. Masaki et al., First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti-interferon-gamma autoantibodies, New Microbes New Infect, vol.27, pp.4-6, 2018.

A. Aoki, T. Sakagami, K. Yoshizawa, K. Shima, M. Toyama et al., Clinical Significance of Interferon-? Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease, Clin Infect Dis. 3 avr, vol.66, issue.8, pp.1239-1284, 2018.

X. Xu, X. Lao, C. Zhang, C. Cao, H. Ding et al., Chronic Mycobacterium avium skin and soft tissue infection complicated with scalp osteomyelitis 85 possibly secondary to anti-interferon-? autoantibody formation, BMC, vol.19

S. Y. Patel, L. Ding, M. R. Brown, L. Lantz, T. Gay et al., Anti-IFN-? Autoantibodies in Disseminated Nontuberculous Mycobacterial Infections, J Immunol, vol.175, issue.7, pp.4769-76, 2005.

P. Wongkulab, J. Wipasa, R. Chaiwarith, and K. Supparatpinyo, Autoantibody to Interferon-gamma Associated with Adult-Onset Immunodeficiency in Non-HIV Individuals in Northern Thailand. Rottenberg ME, éditeur, PLoS ONE. 27 sept, vol.8, issue.9, p.76371, 2013.

T. Kampitak, G. Suwanpimolkul, S. Browne, and C. Suankratay, Anti-interferon-? autoantibody and opportunistic infections: case series and review of the literature, Infection. févr, vol.39, issue.1, pp.65-71, 2011.

I. Hase, K. Morimoto, T. Sakagami, Y. Ishii, and J. Van-ingen, Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review

, Diagn Microbiol Infect Dis. 1 août, vol.88, issue.4, p.15, 2017.

P. A. Merkel, T. Lebo, and V. Knight, Functional Analysis of Anti-cytokine Autoantibodies Using Flow Cytometry. Front Immunol, vol.12

T. Nishimura, Y. Fujita-suzuki, M. Yonemaru, K. Ohkusu, T. Sakagami et al., Recurrence of Disseminated Mycobacterium avium Complex Disease in a Patient with Anti-Gamma Interferon Autoantibodies by Reinfection, J Clin Microbiol. avr, vol.53, issue.4, pp.1436-1444, 2015.

C. Lin, C. Shih, H. Ding, J. Lo, C. Wang et al., Identification of a major epitope by anti-interferon-? autoantibodies in patients with mycobacterial disease, Nat Med. sept, vol.22, issue.9, pp.994-1001, 2016.

J. Wipasa, R. Chaiwarith, K. Chawansuntati, J. Praparattanapan, K. Rattanathammethee et al., , p.86

, interferon-? antibodies in HIV-negative immunodeficient patients infected with unusual intracellular microorganisms, Exp Biol Med. avr, vol.243, issue.7, pp.621-627, 2018.

J. Casanova and L. Abel, Genetic dissection of immunity to mycobacteria: the human model, Annu Rev Immunol, vol.20, pp.581-620, 2002.

C. Ku, C. Lin, C. Chu, C. Chan, J. Kong et al., Anti-IFN-? autoantibodies are strongly associated with, J Allergy Clin Immunol. mars, vol.137, issue.3, pp.945-948, 2016.

J. R. Lees, Interferon gamma in autoimmunity: A complicated player on a complex stage, Cytokine. juill, vol.74, issue.1, p.26, 2015.

N. R. Rose and C. Bona, Defining criteria for autoimmune diseases (Witebsky's postulates revisited), Immunol Today. sept, vol.14, issue.9, p.30, 1993.

D. I. Krisnawati, Y. Liu, Y. Lee, Y. Wang, C. Chen et al., Blockade Effects of Anti-Interferon-(IFN-) ? Autoantibodies on IFN-?-Regulated Antimicrobial Immunity, J Immunol Res, 2019.

S. K. Browne and S. M. Holland, Immunodeficiency secondary to anti-cytokine autoantibodies, Curr Opin Allergy Clin Immunol. déc, vol.10, issue.6, p.41, 2010.

, Site de vulgarisation scientifique

. Axiomcafe, , 2013.

B. Camara, Le quantiFERON : qu'est ce que c'est ? à quoi ca sert ? :3. 68. 38-1-e10.pdf

U. Wu, Y. Chuang, W. Sheng, H. Sun, Y. Jhong et al., Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti

T. Koya, C. Tsubata, H. Kagamu, K. Koyama, M. Hayashi et al., Anti-interferon-? autoantibody in a patient with disseminated Mycobacterium avium complex, J Infect Chemother. 1 janv, vol.15, issue.2, p.22, 2009.

W. Lee, J. Huang, T. Wu, M. Lee, C. Yu et al., Patients with inhibitory and neutralizing auto-antibodies to interferon-? resemble the sporadic adult-onset phenotype of Mendelian Susceptibility to

, Mycobacterial Disease (MSMD) lacking Bacille Calmette-Guerin (BCG)-induced diseases, Immunobiology. mai, vol.218, issue.5, pp.762-71, 2013.

H. Fluhr, J. Spratte, S. Heidrich, J. Ehrhardt, F. Steinmüller et al., Heparin inhibits interferon-? signaling in human endometrial stromal cells by interference with the cellular binding of interferon-?, Fertil Steril. mars, vol.95, issue.4, pp.1272-1279, 2011.

L. Ding, A. Mo, K. Jutivorakool, M. Pancholi, S. M. Holland et al., Determination of Human Anticytokine Autoantibody Profiles Using a Particle-Based Approach, J Clin Immunol. avr, vol.32, issue.2, p.45, 2012.

, Cytokine assays: An assessment of the preparation and treatment of blood and tissue samples, Methods. 15 mai, vol.61, issue.1, pp.10-17, 2013.

I. Suárez, C. Lehmann, H. Gruell, J. Graeb, M. Kochanek et al., Repurposing QuantiFERON for Detection of Neutralizing Interferon-? Autoantibodies in Patients With Nontuberculous Mycobacterial Infections, Clin Infect Dis. 1 août, vol.65, issue.3, pp.518-539, 2017.

Y. Kobashi, Y. Obase, M. Fukuda, K. Yoshida, N. Miyashita et al., Clinical Reevaluation of the QuantiFERON TB-2G Test as a Diagnostic Method for Differentiating Active Tuberculosis from Nontuberculous Mycobacteriosis, Clin Infect Dis. 15 déc, vol.43, issue.12, pp.1540-1546, 2006.

, Culture Filtrate Protein 10 CMH : Complexe Majeur d'Histocompatibilité CMV : CytoMégaloVirus CPA : Cellules Présentatrices d'Antigènes CV : Coefficient de Variation CYBB : Cytochrome B-245 Beta Chain DO : Densité Optique EFS : Établissement Français du Sang ELISA: Enzyme-Linked immunoSorbent Assay ESAT-6: Early Secreted Antigenic Target 6 kDa protein ET : Écart-Type HAS : Haute Autorité de Santé HLA: Human Leukocytes Antigene HRP: HoreRadish Peroxidase IgG : Immunoglobulines G IFN gamma: Interféron gamma IKK: Inhibitor of NFkB Kinase IL-12: Interleukine 12 IRF: Interferon Regulatory Factor JAK : Janus Kinase MAI : Maladies Auto-Immunes MNT: Mycobactéries Non Tuberculeuses MSMD: Mendelian Susceptibility to Mycobacterial Disease NADPH: Nicotinamide Adénine Dinucléotide Phosphate NEMO: Nuclear factor-kappa B Essential Modulator NK/NKT: Natural Killer/ Natural Killer T NOC-2: NO C2 domain PBMC: Peripheral Blood Mononuclear Cells PBS: Phosphate-Buffered Saline PHA: Phytohémagglutinine PRR: Pattern Recognition Receptor ROS: Reactive Oxygen Species RPMI: Roswell Park Memorial Institute STAT: Signal Transducers and Activators of Transcription SOCS-1: Suppressor Of Cytokine Signaling 1 SVF : Sérum de Veau Foetal Tb 7.7: Tuberculosis 7.7 TGF: Transforming Growth Factor TLR: Toll-Like Receptor TNF: Tumor Necrosis Factor VIH : Virus de l'Immunodéficience Humaine VZV : Varicella Zoster Virus